Status:
WITHDRAWN
Biomarkers in Samples From Patients With Endometrial Cancer
Lead Sponsor:
Gynecologic Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lynch Syndrome
Recurrent Uterine Corpus Carcinoma
Eligibility:
FEMALE
Brief Summary
This research study is studying biomarkers in samples from patients with endometrial cancer. Studying samples from patients with cancer in the laboratory may help doctors learn more about changes that...
Detailed Description
PRIMARY OBJECTIVES: I. Assess the frequency and spectrum of mutations in fibroblast growth factor receptor 2 (FGFR2) in low-, intermediate-, and/or high-risk endometrioid endometrial cancer from GOG-...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Samples available from one of the following:
- GOG-0210
- Washington University School of Medicine Siteman Cancer Center
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01199250
Start Date
January 1 2010
End Date
May 1 2019
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynecologic Oncology Group
Philadelphia, Pennsylvania, United States, 19103